Steven Witte, MD, PhD, is a first-year rheumatology fellow at Massachusetts General Hospital, Boston.
References
- Mougiakakos D, Krönke G, Völkl S, et al. CD19-targeted CAR T cells in refractory systemic lupus erythematosus. N Engl J Med. 2021 Aug 5;385(6):567–569.
- Orvain C, Boulch M, Bousso P, et al. Is there a place for chimeric antigen receptor T cells in the treatment of chronic autoimmune rheumatic diseases. Arthritis Rheumatol. 2021 Nov;73(11):1954–1965.
Experience All of RheumMadness
During RheumMadness, rheumatology concepts represent teams that compete against each other in a tournament, much like basketball teams do in the NCAA’s March Madness tournament. In a series for The Rheumatologist, readers will get a chance to read the scouting reports. Check out the reports from each region:
Region: Cells
Region: Animal House
Region: Machines
Region: People
• False Positive MRI in Axial SpA
Don’t forget to submit your RheumMadness 2022 bracket by March 25. The winner of each match-up is decided by a seven-member Blue Ribbon Panel of rheumatologists. The panel will vote based on which topic they think is most important to patients, providers and researchers—both now and in the future. The more your picks match those of the panel, the more points you get. The tournament results will be released in four rounds from March 26–April 4. Prizes will be given to participants with the top scores in the following categories: 1) attending/APP, 2) fellow and 3) resident/medical student. The prize is a custom RheumMadness coffee mug and a lifetime of bragging rights.
Connect with RheumMadness by subscribing to the podcast and joining the conversation on Twitter, #RheumMadness. Learn on the RheumMadness website.
